Cephalon Gabitril REMS gets FDA approval - Pharmaceutical Business Review

Links shared publicly online about this topic.

  • 800
    total visits

Cephalon Gabitril REMS gets FDA approval - Pharmaceutical Business Review

packaging.pharmaceutical-business-review.com

Cephalon said that a Risk Evaluation and Mitigation Strategy (REMS) for its antiepileptic medication Gabitril (tiagabine hydrochloride) has been appro

View full resource at packaging.pharmaceutical-business-review.com

Tags: Drug, Pharma, FDA, Cephalon, News

  • Share

Most Recently Shared on October 15, 2010 at 6:49 am By:

Advertisement